Charles Engh, MD
Adult Reconstructive Orthopaedic Surgery · Arlington, VANPI 1457305633
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $4,049 of the $4,297 with a category attached, or 94.2%. Depuy Synthes Products, Inc. accounts for 94.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $2,079 and has fallen 91.9% since, to $168 in 2022. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in VA, where the typical reported total is $8,085.
Across 9 payments — averaging $477.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$4K
- Zimmer Biomet$211
- Medical Device Business Services, Inc.$37
Across 17 payments — averaging $2727.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$46K
What the payments were for
- Royalty or licence$4,04994%
- Food & beverage$2486%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 6 | $4,049 |
| Zimmer Biomet | 2 | $211 |
| Medical Device Business Services, Inc. | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUMATCH$3,915
How this compares
$4,297 in reported general payments places this provider in the 30th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.
See all adult reconstructive orthopaedic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 42 | $1,182 |
| Naproxen | 30 | $131 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Arlington
- Nitin GoyalArlington$81.5M
- Charles EnghArlington$5.5M
- Robert SershonArlington$94K
- Aaron GebrelulArlington$21K
- Kurtis CarlockArlington$16K
- Jacob ZalewskiArlington$7K
- Nigel AzerArlington$412
- Andrew HolmesArlington$24
- William HamiltonAlexandria$9.3M
- James BrowneCharlottesville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.